SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...

At the 2025 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium, Alexa Meara, MD, explored the interface of oncology and rheumatology in the immunotoxicity ...

A proposal tying U.S. drug prices to those of foreign nations would close clinics and diminish options for patients.

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for all four formulations of Gobivaz - Alvotech ...

Arthritis can make everyday tasks difficult and painful. What you eat may impact the intensity of your arthritis pain. To ...

Another common feature: Patients with a number of autoimmune diseases, especially women, often suffer heart attacks and ...

If you have arthritis in your hands, it's important for you to strength train regularly. These are the best exercise ...

GLP-1RA use was associated with a lower incidence of rheumatic diseases such as rheumatoid arthritis, gout, and osteoarthritis relative to DPP-4is.

Current therapies such as biological DMARDs showed promising results in treating rheumatoid arthritis patients, and market penetration is expected to be more in the future and expected to drive market ...

Approximately 5 million persons in the United States have psoriasis.1 Most have mild disease covering less than 3% of body-surface area, but approximately one fifth have more extensive involvement ...

Patients with psoriatic arthritis who received GLP-1 receptor agonists exhibited lower risks for mortality and cardiovascular ...